
Emma Lees, PhD,
Vice President and Oncology Site Head, Bristol-Myers Squibb

Chad May, PhD,
Senior Vice President, Research and Development, Maverick Therapeutics

Juliet Williams, PhD,
Executive Director, Oncology Drug Discovery, Novartis

Johan Luthman, PhD, SVP,
Neuroscience Clinical Development, Neurology Business Group, Eisai, Inc.

Christoph Patsch, PhD,
Team Lead Stem Cell Assays, Disease Relevant Cell Models and Assays, Chemical Biology, Therapeutic Modalities, Roche

Gabriele Proetzel, PhD,
Director, Regenerative Medicine, Takeda Pharmaceuticals, Inc

Gary Gintant, PhD,
Senior Research Fellow, AbbVie

Holly D. Soares, PhD,
Head, Translational Neuroscience, AbbVie

Nicholas Brandon, PhD,
Chief Scientist, Neuroscience, IMED, AstraZeneca

Laszlo Urban, MD, PhD,
Global Head, Preclinical Secondary Pharmacology, Novartis Institutes for Biomedical Research (NIBR)

Jason Ekert, PhD,
Head, Complex in vitro Models, R&D Platform Technology & Science, GlaxoSmithKline

Raghu Kalluri, MD, PhD,
Professor and Chair, Department of Cancer Biology, University of Texas MD Anderson Cancer Center